Research Article

Clinically Symptomatic Pericardial Effusions in Hospitalized Systemic Sclerosis Patients: Demographics and Management

Table 2

Individual clinical characteristics of SSc patients with pericardial disease.

PatientAgeType of SScDiagnosisOverlap syndromeSize of pericardial effusionPresence of tamponadeRight heart failureProcedureFluid studyMeds prior to admission

160UnknownM-L-Severe
271Limited+ (PM, MCTD)M-MildThoracentesisPleural fluid: transudative (LDH 88, Pr 1.3, NUC 63, seg 52)
360UnknownL-SevereIloprost, sildenafil, bosentan, and plaquenil
468UnknownM-L-
562LimitedNewM-L+Severe
661DiffuseM-L-Methylprednisolone
755LimitedM-MildTreprostinil, macitentan, sildenafil
865UnknownS-Mycophenolate, tacrolimus, and prednisone
979UnknownL-Severe
1066Limited28 yrsM-Ambrisentan, nifedipine
1157UnknownM-Nifedipine
1249UnknownM-
1372UnknownNewM-ModerateNifedipine, ibuprofen
1459UnknownNew+ (IBM)M-L-
1563Limited2 yrs+ (Sicca)M-SevereCevimeline, candesartan
1658Unknown13 yrsL-ModerateAmbrisentan, sildenafil, iloprost, and mycophenolate
1757Unknown14 yrsM-L+SevereThoracentesisMacitentan, mycophenolate, and sildenafil
1856LimitedL+Mod-severeSildenafil
1956Diffuse2 moL-PericardiocentesisWBC 178, RBC 9, GS neg, Cx neg, cytology negMethotrexate, prednisone
2048Diffuse8 yrs+ (MCTD)L-Pericardiocentesis → pericardial windowWBC 240, RBC 3550, pleural fluid: no malignancy, reactive mesothelial cells, and chronic inflammationLisinopril
2144DiffuseNewL-Pericardiocentesis → pericardial windowCytology neg, AFB neg
2266DiffuseNewL+Pericardiocentesis → pericardial windowWBC 568, RBC 815, GS neg, and cytology negPrednisone
2345Diffuse7 mo+ (RA, Sjogren, DM)M-Pericardial windowMethotrexate, plaquenil

S = small, M = moderate, L = large, PM = polymyositis, IBM = inclusion body myositis, MCTD = mixed connective tissue disease, RA = rheumatoid arthritis, and DM = dermatomyositis.